Nanostics Announces Publication of a ClarityDX Prostate Study Validating New Algorithms with Improved Cancer Prediction that make MRI or DRE Optional
EDMONTON, AB, April 20, 2026 /PRNewswire/ – Nanostics Inc., a precision health company advancing diagnostic innovation through its ClarityDX®…